| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521653 Microbicidal benzotriazoles |
| 02/18/2003 | US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity |
| 02/13/2003 | WO2003011869A1 Radioligands and their use for identifying potassium channel modulators |
| 02/13/2003 | WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/13/2003 | WO2002088146A3 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-e]INDOLE |
| 02/13/2003 | WO2001072754A8 Alkylated imidazopyridine derivatives |
| 02/13/2003 | US20030033089 Substituted quinazolines and analogs and the use thereof |
| 02/13/2003 | US20030032652 Hydroxamic and carboxylic acid derivatives |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/13/2003 | US20030032624 Esterifying camptothecin or a derivative with an aminoalkanoic acid or an imidoalkanoic acid and camptothecin; useful for treating cancer. |
| 02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/12/2003 | EP1283043A1 Ophthalmic solution |
| 02/12/2003 | EP1283042A1 Aqueous liquid preparation |
| 02/12/2003 | EP1282630A1 Hydroxylamine esters as polymerization initiators |
| 02/12/2003 | EP1003724B1 Substituted quinoline derivatives with antiviral action |
| 02/12/2003 | EP0947514B1 Novel phenanethridinium derivatives |
| 02/12/2003 | EP0926146B1 Chromene compounds |
| 02/12/2003 | EP0863906B1 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 02/12/2003 | EP0793497B1 Novel enediyne quinone imines and methods of preparation and use thereof |
| 02/11/2003 | US6518430 Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof |
| 02/11/2003 | US6518427 Compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of these compounds. They are also rapidly converted back to the parent amines in vivo, making them useful as prodrugs of the parent amines. |
| 02/11/2003 | US6518426 Pyrimidine derivatives and methods of making and using these derivatives |
| 02/11/2003 | US6518421 Process for the preparation of epothilone analogs |
| 02/11/2003 | US6518294 Fused pyrazolyl compounds |
| 02/11/2003 | US6518265 1H-imidazopyridine derivatives |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 02/06/2003 | WO2003010230A1 Method of mass-colouring synthetic materials |
| 02/06/2003 | WO2003010175A2 Radiolabeled neuropeptide y y5 receptor antagonists |
| 02/06/2003 | WO2003010169A1 Antidepressant azaheterocyclylmethyl derivatives of 7, 8-dihydro-6h-5-oxa-1-aza-phenanthrene |
| 02/06/2003 | WO2003010158A1 Novel compounds |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2003010138A2 Piperidine derivatives as antibacterial agents |
| 02/06/2003 | WO2003009852A1 Tyrosine kinase inhibitors |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV) |
| 02/06/2003 | US20030027842 Halogenobenzimidazoles |
| 02/05/2003 | EP1280813A1 Anti-viral pyrimidine nucleoside analogues |
| 02/05/2003 | EP1280809A1 Antitumoral ecteinascidin derivatives |
| 02/05/2003 | EP1280798A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 02/05/2003 | EP1280770A1 C 2? phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 02/05/2003 | EP1086078B1 Neuropeptide y5 receptor antagonists |
| 02/05/2003 | EP0758334B1 Substituted (1,4)dioxino(2,3-f)benzoimidazole derivatives and their use in pest control |
| 02/05/2003 | CN1395507A Catalysts comprising N-substituted cyclic imides and processes for prepairing organic compounds with catalysts |
| 02/05/2003 | CN1100780C Process for preparing 2-chloro-beziidazole derivatives |
| 02/04/2003 | US6515135 Aminoaryl oxazolidinone N-oxides |
| 02/04/2003 | US6515126 Chemical synthesis of spirocyclic piperidines by double ring-closing metathesis |
| 02/04/2003 | US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents |
| 02/04/2003 | US6514984 Human non-pancreatic secretory phospholipase A2 inhibitors |
| 02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
| 01/30/2003 | WO2003008421A1 Process for preparation of amidine derivatives |
| 01/30/2003 | WO2003008420A1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]naphthalenyl derivatives with antipsychotic activity |
| 01/30/2003 | WO2003008419A1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA[a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY |
| 01/30/2003 | WO2003008410A2 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | WO2003007966A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 01/30/2003 | WO2002088079A3 Dual inhibitors of pde 7 and pde 4 |
| 01/30/2003 | WO2002012247A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/30/2003 | WO2002000617A3 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/30/2003 | US20030023082 Epothilone derivatives and methods for making and using the same |
| 01/30/2003 | US20030022913 Novel immunomodulating compounds |
| 01/30/2003 | US20030022905 Prevention and/or therapy of ischaemia and reperfusion damage; poly(ADP-ribose)-synthetase inhibitors |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | CA2454545A1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]naphthalenyl derivatives with antipsychotic activity |
| 01/30/2003 | CA2454543A1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]naphthalenyl derivatives with antipsychotic activity |
| 01/30/2003 | CA2453664A1 Process for preparation of amidine derivatives |
| 01/30/2003 | CA2453636A1 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | CA2417804A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2003 | EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/29/2003 | EP1278746A2 Dihydropyridine compounds and methods of use |
| 01/29/2003 | EP1278742A1 Chromenylmethylpyrimidinediamines as antibacterial agents |
| 01/29/2003 | EP1278739A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor |
| 01/29/2003 | EP1278526A2 Treatment of cerebrovascular disease |
| 01/29/2003 | EP1278502A2 Protease inhibitors |
| 01/29/2003 | EP1161434B1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 01/29/2003 | EP1033369B1 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 01/29/2003 | EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/29/2003 | EP0754175B1 Alkoxy-alkyl-substituted 1-h-3-aryl-pyrrolidine-2,4-diones used as herbicides and pesticides |
| 01/29/2003 | CN1393446A 稠合吡唑化合物 Fused pyrazole compounds |
| 01/29/2003 | CN1100058C Novel intermediates and process for manufacture of camptothecin derivatives (CPT-11) and related compounds |
| 01/29/2003 | CN1100057C Chromene compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/28/2003 | WO2002018372A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 01/28/2003 | US6512120 Functionalized pyrrolidine compounds through the use of intramolecular Diels Alder reactions. further in situ and resin-bound synthetic generation of chemical libraries. |
| 01/28/2003 | US6512112 Useful as prodrugs, easily convert to parent amine in vivo; antibiotic activity versus gram negative aerobic and anaerobic bacteria |
| 01/28/2003 | US6511986 Method of treating estrogen receptor positive carcinoma |
| 01/28/2003 | US6511977 For preventing or treating cardiac arrhythmia or atrial arrhythmia |
| 01/28/2003 | US6511942 Animal husbandry, veterinary medicine |
| 01/23/2003 | WO2003006563A1 A compressed fluid formulation |
| 01/23/2003 | WO2003006060A1 Sh3 domain binding inhibitors |
| 01/23/2003 | WO2002066475A3 Tricyclic androgen receptor modulator compounds |
| 01/23/2003 | WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/23/2003 | WO2002034760A3 Compounds and methods |
| 01/23/2003 | WO2002017893A3 Sgk2 and sgk3 used as diagnostic and therapeutic targets |
| 01/23/2003 | US20030018199 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 01/23/2003 | US20030018046 Chemokine receptor binding heterocyclic compounds |
| 01/23/2003 | US20030018042 Psychological disorders; Alzheimer's disease |
| 01/23/2003 | CA2417156A1 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient |
| 01/22/2003 | EP1277756A1 Ketol fatty acid derivatives and plant growth regulating agents |